Complications of use of intrauterine devices among HIV-1-infected women
Authors:
- Charles S MorrisonCMCharles S Morrison
- Christine Sekadde-KigonduCSChristine Sekadde-Kigondu
- Melissa AllenMAMelissa Allen
- Donald KokonyaDKDonald Kokonya
- 1 April 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 351 (9111) , 1238-1241
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vaginaThe Lancet, 1997
- Pelvic inflammatory disease in HIV-positive womenThe Lancet, 1997
- Pelvic Inflammatory Disease and Human Immunodeficiency Virus InfectionObstetrics & Gynecology, 1997
- Detection of HIV DNA in Cervical and Vaginal SecretionsJAMA, 1993
- Intrauterine devices and pelvic inflammatory disease: an international perspectiveThe Lancet, 1992
- Man-to-Woman Sexual Transmission of the Human Immunodeficiency VirusArchives of internal medicine (1960), 1991
- Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertionAdvances in Contraception, 1991
- Sexually transmitted diseases and human immunodeficieny virus infection among women with pelvic inflammatory diseaseAmerican Journal of Obstetrics and Gynecology, 1990
- Preventing IUCD‐related pelvic infection: the efficacy of prophylactic doxycycline at insertionBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATIONAmerican Journal of Epidemiology, 1989